Offices:
Valladolid, Madrid
Investors:
we tracked 2 investors
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Total investments received (USD) - we tracked 2 transactions
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Amadix is a biotechnology company constituted by the partners of TCD Pharma for the development of diagnostic tools in the area of oncology, with several very advanced programs in lung and colon cancer. Its solution, called Colofast, allows to detect if a healthy person will suffer from colon cancer up to fifteen years before showing the first symptoms.
Companies with similar profile to Amadix:
| Company | Criteria |
|---|
 Ability Pharma56% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- At least one vc investor: Inveready
- Minim one investor from outside Scandinavia: Yes
|
| Parlem Telecom 54% | - Similar business models: B2B
- At least one vc investor: Inveready
- At least one other investor: TheCrowdAngel
- Total raised in a similar range: 5M - 10M USD
- Minim one investor from outside Scandinavia: Yes
|
| ViveBiotech 45% | - Similar verticals: Health services
- Similar business models: B2B
- At least one vc investor: Inveready
- Minim one investor from outside Scandinavia: Yes
|
 NMD Pharma44% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
| STipe Therapeutics 44% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
 Gesynta Pharma44% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
|
| Asarina Pharma 44% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
| AFYX Therapeutics 44% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
| Cirqle Biomedical 44% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
| Gradientech 44% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
|
| Trialbee 44% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
|
 Forendo Pharma44% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
| ITBMed 44% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
 3Z Pharmaceuticals44% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
| iCellate 44% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
|
 CardioMech43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
- Minim one investor from outside Scandinavia: Yes
|
| Prediktor 43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
- Minim one investor from outside Scandinavia: Yes
|
| AMRA 43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
- Minim one investor from outside Scandinavia: Yes
|
| Desentum 43% | - Similar verticals: Pharma
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
- Minim one investor from outside Scandinavia: Yes
|
| Aiforia 43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
- Minim one investor from outside Scandinavia: Yes
|
